日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

An Accurate and Automated Method for Adenoma Detection Rate and Report Card Generation Utilizing Common Electronic Health Records

利用常用电子健康记录进行腺瘤检出率和报告卡生成的精确自动化方法

Ganguly, Eric K; Purvis, Luke; Reynolds, Nathan; Akram, Siddique; Lidofsky, Steven D; Zubarik, Richard

Attacking the public health crisis of hepatocellular carcinoma at its roots

从根源上解决肝细胞癌这一公共卫生危机

Lee, Hannah M; Lidofsky, Steven D; Taddei, Tamar H; Townshend-Bulson, Lisa J

Nonalcoholic fatty liver disease and cognitive impairment: A prospective cohort study

非酒精性脂肪性肝病与认知障碍:一项前瞻性队列研究

Cushman, Mary; Callas, Peter W; Alexander, Kristine S; Wadley, Virginia; Zakai, Neil A; Lidofsky, Steven D; Unverzagt, Frederick W; Judd, Suzanne E

Statewide Assessment of the Hepatitis C Virus Care Cascade for Incarcerated Persons in Vermont

佛蒙特州对被监禁人员丙型肝炎病毒治疗级联的全州评估

Hale, Andrew J; Mathur, Shivani; Dejace, Jean; Lidofsky, Steven D

LOXL-2 and TNC-C are markers of liver fibrogenesis in HCV/HIV-, HIV- and HCV-infected patients

LOXL-2 和 TNC-C 是 HCV/HIV 合并感染、HIV 和 HCV 合并感染患者肝纤维化的标志物。

Altinbas, Akif; Holmes, Jacinta A; Salloum, Shadi; Lidofsky, Anna; Alatrakchi, Nadia; Somsouk, Ma; Hunt, Peter; Deeks, Steven; Chew, Kara W; Lauer, Georg; Kruger, Annie; Lin, Wenyu; Chung, Raymond T

A Long Noncoding RNA Regulates Hepatitis C Virus Infection Through Interferon Alpha-Inducible Protein 6

长链非编码 RNA 通过干扰素 α 诱导蛋白 6 调控丙型肝炎病毒感染

Xiao Liu, Xiaoqiong Duan, Jacinta A Holmes, Wenting Li, Sae Hwan Lee, Zeng Tu, Chuanlong Zhu, Shadi Salloum, Anna Lidofsky, Esperance A Schaefer, Dachuan Cai, Shilin Li, Haoju Wang, Yongfu Huang, Yongju Zhao, Ming-Lung Yu, Zhiwen Xu, Limin Chen, Jian Hong, Wenyu Lin, Raymond T Chung

Development and Implementation of a Culturally Appropriate Education Program to Increase Cervical Cancer Screening among Maasai Women in Rural Tanzania

制定并实施一项符合文化背景的教育计划,以提高坦桑尼亚农村马赛族妇女的宫颈癌筛查率

Lidofsky, A; Miller, A; Jorgensen, J; Tajik, A; Tendeu, K; Pius, D; Mallange, E; Dougherty, A

Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis

酪氨酸激酶SYK是肝纤维化的潜在治疗靶点。

Qu, Chen; Zheng, Dandan; Li, Sai; Liu, Yingjun; Lidofsky, Anna; Holmes, Jacinta A; Chen, Jianning; He, Lu; Wei, Lan; Liao, Yadi; Yuan, Hui; Jin, Qimeng; Lin, Zelong; Hu, Qiaoting; Jiang, Yuchuan; Tu, Mengxian; Chen, Xijun; Li, Weiming; Lin, Wenyu; Fuchs, Bryan C; Chung, Raymond T; Hong, Jian

Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection.

巨噬细胞活化标志物可溶性 CD163 是人类免疫缺陷病毒/丙型肝炎病毒合并感染中肝纤维化的动态标志物

Lidofsky Anna, Holmes Jacinta A, Feeney Eoin R, Kruger Annie J, Salloum Shadi, Zheng Hui, Seguin Isabel S, Altinbas Akif, Masia Ricard, Corey Kathleen E, Gustafson Jenna L, Schaefer Esperance A, Hunt Peter W, Deeks Steven, Somsouk Ma, Chew Kara W, Chung Raymond T, Alatrakchi Nadia

Non-alcoholic fatty liver disease, liver biomarkers and stroke risk: The Reasons for Geographic and Racial Differences in Stroke cohort

非酒精性脂肪肝病、肝脏生物标志物和中风风险:中风队列中地域和种族差异的原因

Alexander, Kristine S; Zakai, Neil A; Lidofsky, Steven D; Callas, Peter W; Judd, Suzanne E; Tracy, Russell P; Cushman, Mary